BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3535840)

  • 21. Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker.
    Washio K; Inagaki M; Tsuji M; Morio Y; Akiyama S; Gotoh H; Gotoh T; Gotoh Y; Oguchi K
    Nephron Clin Pract; 2008; 109(2):c49-54. PubMed ID: 18544955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients.
    Deicher R; Ziai F; Bieglmayer C; Schillinger M; Hörl WH
    J Am Soc Nephrol; 2005 Jun; 16(6):1811-8. PubMed ID: 15814831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma ascorbic acid concentrations in prevalent patients with end-stage renal disease on hemodialysis.
    Sirover WD; Liu Y; Logan A; Hunter K; Benz RL; Prasad D; Avila J; Venkatchalam T; Weisberg LS; Handelman GJ
    J Ren Nutr; 2015 May; 25(3):292-300. PubMed ID: 25455040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ankyrin is the major oxidised protein in erythrocyte membranes from end-stage renal disease patients on chronic haemodialysis and oxidation is decreased by dialysis and vitamin C supplementation.
    Ruskovska T; Bennett SJ; Brown CR; Dimitrov S; Kamcev N; Griffiths HR
    Free Radic Res; 2015 Feb; 49(2):175-85. PubMed ID: 25426774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of vitamin C on heparin activity in patients with chronic renal failure treated with hemodiaglysis].
    Chmielewska J; Poplawski A
    Pol Tyg Lek; 1977 Jul; 32(28):1079-80. PubMed ID: 887495
    [No Abstract]   [Full Text] [Related]  

  • 26. Lipoperoxidation and hemodialysis.
    Ramos R; Martínez-Castelao A
    Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The significance of regular dialysis in the treatment of terminal renal insufficiency].
    Susa S
    Vojnosanit Pregl; 1977; 34(5):327-31. PubMed ID: 602057
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Supply of ascorbic acid requirement in chronic kidney insufficiency and its modification by means of extracorporeal hemodialysis].
    Kasper H; Muskat E; Mueller K
    Klin Wochenschr; 1970 Aug; 48(15):946-7. PubMed ID: 5519313
    [No Abstract]   [Full Text] [Related]  

  • 30. New insight on vitamin C in patients with chronic kidney disease.
    Handelman GJ
    J Ren Nutr; 2011 Jan; 21(1):110-2. PubMed ID: 21195931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical report on hemodialysis in the Department of Transplantation, Tokai University School of Medicine.
    Hida M; Saitoh H; Shiramizu T; Nakamura K; Shinbo T; Nakayama M; Satoh T
    Tokai J Exp Clin Med; 1981 Jul; 6(3):247-57. PubMed ID: 7303005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of ascorbic acid in suboptimal responsive anemic hemodialysis patients receiving erythropoietin: a meta-analysis.
    Einerson B; Chaiyakunapruk N; Kitiyakara C; Maphanta S; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S134-46. PubMed ID: 21721439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of an integrated program of hemodialysis and kidney transplants. Results in 102 cases in 5 years].
    Knijnik R; Burmeister JE; Grillo FM; Biernat JC
    AMB Rev Assoc Med Bras; 1978 Jul; 24(7):226-8. PubMed ID: 362490
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of hemodialysis and transplantation in the treatment of end-stage renal failure secondary to diabetic nephropathy.
    Passer J; Ware F; Steenburg R; Stone DB
    Nebr Med J; 1976 Dec; 61(12):459-63. PubMed ID: 794744
    [No Abstract]   [Full Text] [Related]  

  • 35. Observation of hemodialysis patients at our center.
    Ozdemir FN; Erten Y; Kahveci E; Kaya S; Bilgin N
    Transplant Proc; 1996 Aug; 28(4):2343-4. PubMed ID: 8769247
    [No Abstract]   [Full Text] [Related]  

  • 36. [L-ascorbic acid and long-term dialysis program].
    Mydlík M; Derzsiová K; Takác M
    Cas Lek Cesk; 1976 Jan; 115(4):115-9. PubMed ID: 1253213
    [No Abstract]   [Full Text] [Related]  

  • 37. Replacement therapy for end-stage renal failure.
    Ward MK
    Practitioner; 1981 Jul; 225(1357):1009-17. PubMed ID: 7031629
    [No Abstract]   [Full Text] [Related]  

  • 38. [Demonstration of a vitamin P. P. deficiency in chronic insufficiency treated by repeated supplementary hemodialysis].
    Gross A; Ponsin D; Labidi B; Prenat E; Rivory JP; Nicolas JP
    J Urol Nephrol (Paris); 1978; 84(4-5):312-8. PubMed ID: 150465
    [No Abstract]   [Full Text] [Related]  

  • 39. [Indications for renal transplantation. Choice between hemodialysis and transplantation].
    Crosnier J
    Soins; 1982 Aug; (387-388):5-7. PubMed ID: 6755722
    [No Abstract]   [Full Text] [Related]  

  • 40. Ineffectiveness of vitamin C in treating coryza.
    Practitioner; 1968 Mar; 200(197):442-5. PubMed ID: 4870463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.